A synthesis of 1 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Worrying link between cannabis use and anxiety revealed in new study and the impact … – UNILAD
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthAnxietyTHC Why This Matters This decade-long cohort study from McMaster University provides longitudinal evidence...
Link between cannabis and anxiety, depression has ‘strengthened over time’: new study
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AnxietyMental HealthResearchSafety Why This Matters This study adds to the growing body of evidence that...
Link between cannabis and anxiety, depression has ‘strengthened over time’ – NY Post
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Mental HealthAnxietyResearchSafety Why This Matters This finding is clinically significant because it challenges the common...
Study Finds Cannabis Use, Anxiety, and Depression Rising in Canada
Canadian data links cannabis anxiety treatment evidence to rising depression rates, raising clinical questions about therapeutic use patterns and mental…
Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News
WHY IT MATTERS: Patients using cannabis to manage anxiety or depression should be aware that without proper medical guidance on strain selection, THC-to-CBD ratios, and dosing, cannabis may be worsening the very symptoms they are trying to treat. CLINICAL OVERVIEW: Research from Canada is highlighting a parallel rise in cannabis use alongside increasing rates of anxiety and depression, raising important questions about the direction of causality and the role cannabis may be playing in mental health outcomes. The relationship between cannabis and mood disorders is complex, as individuals may be turning to cannabis to self-manage psychological distress while the substance itself, particularly high-THC products, can worsen anxiety and depressive symptoms over time.
The Week in Weed: February 27, 2026 – Lexology
WHY IT MATTERS: Patients starting cannabis therapy should understand that acute effects, including changes in perception, heart rate, and cognition, are time-limited but real, and knowing what to expect helps reduce anxiety and supports safer, more informed use. CLINICAL OVERVIEW: Research from the University of Calgary and Washington State University has added to the growing body of evidence examining how cannabis affects the body acutely, with findings pointing to measurable physiological and psychoactive responses following cannabis use. Understanding acute cannabis effects is clinically relevant because these short-term changes inform how patients should be counseled around timing, setting, and dose when initiating or adjusting therapy.
Nebraska Bill Seeks To Shield Doctors Recommending Medical Cannabis From Arrest
WHY IT MATTERS: Nebraska patients who qualified for medical cannabis under the state’s voter-approved program may finally gain access to physicians willing to recommend it without fear of legal consequences. CLINICAL OVERVIEW: Nebraska is taking a meaningful step toward protecting physicians who recommend medical cannabis by advancing legislation that would grant them immunity from arrest. This kind of legal protection is foundational to good medicine because physicians cannot practice effectively when facing criminal liability for evidence-informed clinical decisions.
"Mother of Cannabinoids": The Rising Potential of CBG and CBG-A – Cannabis Health News
WHY IT MATTERS: Patients who have not found adequate relief from CBD or THC-based products may soon have access to better-studied CBG formulations targeting anxiety and cognitive symptoms, but those conversations with a clinician should happen before swapping or adding products. CLINICAL OVERVIEW: Cannabigerol (CBG) and its acidic precursor cannabigerolic acid (CBGA) are gaining serious scientific attention as researchers examine their potential roles in anxiety reduction, memory enhancement, and anti-cancer activity. CBGA is often called the “mother of cannabinoids” because it serves as the biosynthetic precursor from which THC, CBD, and CBC are all derived, making it a foundational compound in the cannabis plant’s chemistry.
Daily Digest: Last 24 Hours: Adolescent Brain Risk, Cannabis and Mood Disorders, and Regulatory Growing Pains — February 27, 2026
Last 24 Hours February 27, 2026 — 30 articles reviewed This cycle’s coverage centered on the psychiatric vulnerability of young brains exposed to high-potency THC, a recurring signal linking cannabis use to...